| Gene symbol | CD19 | Synonyms | B4, CVID3 | Type of gene | protein-coding |
| Chromosome | 16 | Map location | 16p11.2 | dbXrefs | |
| Description | CD19 molecule | ||||
| GTO ID | GTC2064 |
| Trial ID | NCT03854994 |
| Disease | B-Cell Acute Lymphoblastic Leukemia | B-Cell Lymphoma |
| Altered gene | CD19 |
| Therapeutic/Target gene | Target gene |
| Therapy | CAR-T cell |
| Treatment | KD-019 CAR-T cells |
| Generation | 2nd |
| Phase | Phase1 |
| Recruitment status | Unknown |
| Title | CD19 CAR-T Cell Therapy for Relapsed/Refractory B-cell Lymphoma and B-cell Acute Lymphoblastic Leukemia |
| Year | 2019 |
| Country | China |
| Company sponsor | Yan'an Affiliated Hospital of Kunming Medical University |
| Other ID(s) | 201707202 |
| Cohort 1 | |||||||||||
|
|||||||||||